Market Value402,255,734
Total Holdings61
File Date2023-11-08
Original Filing (Click here)

All hedge funds or institutions that manage over $100M are required by the SEC to file quarterly reports on their holdings. These reports are called 13F reports. However, the filings are required the following quarter from the reporting period, which means that by the time the filing is made (and we see them), the information could be five months old.

For funds with long term positions that make few trades, the holdings might closely resemble their current holdings, even after several months. However, for funds that have high turnover, the holdings data we see might differ significantly from their current holdings. Institutions are required to report CALL and PUT options, and those positions are identified in the table. However, they are not required to report short positions.

Click the link icon to see the full transaction history.

Upgrade to unlock premium data and export to Excel .

Security Imputed
Share Price
Prev
Shares
Current
Shares
Change
(Percent)
Prev Value
(USD x1000)
Current Value
(USD x1000)
Change
(Percent)
QGEN / Qiagen N.V.
AMRN / Amarin Corporation plc - Depositary Receipt (Common Stock) Put
PNTG / The Pennant Group, Inc.
HCA / HCA Healthcare, Inc.
AUTL / Autolus Therapeutics plc - Depositary Receipt (Common Stock)
ELV / Elevance Health, Inc.
PBYI / Puma Biotechnology, Inc.
HUM / Humana Inc.
BCRX / BioCryst Pharmaceuticals, Inc.
CNC / Centene Corporation
DHR / Danaher Corporation
CYH / Community Health Systems, Inc.
OTIC / Otonomy Inc
TGTX / TG Therapeutics, Inc.
EHTH / eHealth, Inc.
LQDA / Liquidia Corporation
TARO / Taro Pharmaceutical Industries Ltd.
DXCM / DexCom, Inc.
XENE / Xenon Pharmaceuticals Inc.
AZN / AstraZeneca PLC - Depositary Receipt (Common Stock)
RDUS / Radius Recycling, Inc.
RDUS / Radius Recycling, Inc. Call
NTRA / Natera, Inc.
APLS / Apellis Pharmaceuticals, Inc.
FATE / Fate Therapeutics, Inc.
SCPH / scPharmaceuticals Inc.
US3723091043 / GenMark Diagnostics, Inc
US62857M1053 / MyoKardia, Inc.
SESN / Sesen Bio Inc.
AQST / Aquestive Therapeutics, Inc.
ZGNX / Zogenix Inc
ZGNX / Zogenix Inc Call
CTRE / CareTrust REIT, Inc.
ASND / Ascendis Pharma A/S - Depositary Receipt (Common Stock)
/ Oxford Immunotec Global PLC
BOLD / Boundless Bio, Inc.
MDCO / Medicines Company
FTSV / Forty Seven, Inc.
AKRX / Akorn, Inc.
RCM / R1 RCM Inc.
XLRN / Acceleron Pharma Inc
HSKA / Heska Corp. (Restricted Voting)
BDSI / Biodelivery Sciences International
KDMN / Kadmon Holdings Inc
TARA / Protara Therapeutics, Inc.
US60877T1007 / Momenta Pharmaceuticals, Inc.
US7170711045 / Pfenex Inc.
ALBO / Albireo Pharma Inc
BLUE / bluebird bio, Inc.
ALGN / Align Technology, Inc. Put
SNY / Sanofi - Depositary Receipt (Common Stock)
CYTK / Cytokinetics, Incorporated
ARGX / argenx SE - Depositary Receipt (Common Stock)
DRNA / Dicerna Pharmaceuticals Inc
EIGR / Eiger BioPharmaceuticals, Inc.
SBRA / Sabra Health Care REIT, Inc.
TGTX / TG Therapeutics, Inc. Call
NVST / Envista Holdings Corporation
SPY / SPDR S&P 500 ETF Put
AGRX / Agile Therapeutics, Inc.
TLGT / Teligent Inc
AL / Air Lease Corporation Put
VRTX / Vertex Pharmaceuticals Incorporated
GSK / GSK plc - Depositary Receipt (Common Stock)
AFMD / Affimed N.V.
OHI / Omega Healthcare Investors, Inc.
GH / Guardant Health, Inc.
SPPI / Spectrum Pharmaceuticals, Inc. Put
SRPT / Sarepta Therapeutics, Inc.
BHVN / Biohaven Ltd.
CCXI / ChemoCentryx Inc
IOVA / Iovance Biotherapeutics, Inc.
COLL / Collegium Pharmaceutical, Inc.
DCPH / Deciphera Pharmaceuticals, Inc.
MODN / Model N, Inc.
CYCN / Cyclerion Therapeutics, Inc.
LTC / LTC Properties, Inc.
ENSG / The Ensign Group, Inc.
IFRX / InflaRx N.V.
IGMS / IGM Biosciences, Inc.
IMVT / Immunovant, Inc.
MGNX / MacroGenics, Inc.
AMRN / Amarin Corporation plc - Depositary Receipt (Common Stock)
AMRN / Amarin Corporation plc - Depositary Receipt (Common Stock) Call